Rheinische Compounding GmbH operates at its Bonn site a pharmaceutical manufacturing facility producing ready-to-use, individualized parenteral infusion solutions. It supports public and hospital pharmacies in cooperation with medical practices, outpatient clinics and hospitals and additionally provides consulting services on manufacturing matters. The company has been part of the NewCo Pharma group structure since the 2015 fiscal year; the sole shareholder is NewCo Pharma GmbH. In November 2021 the merger of the NewCo Pharma group with Medios AG was agreed and was closed on January 10, 2022, expanding the manufacturing network.
ist der Aufbau und Betrieb einer pharmazeutischen Herstellungsstätte zur Herstellung von sterilen Arzneimitteln, ferner die Erbringung von Beratungsleistungen in dieser Hinsicht.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Bonn Local Court, HRB 15768 (as of 27 September 2026)
Source: German Commercial Register (Handelsregister) Bonn Local Court, HRB 15768 (as of 27 September 2026)
Source: German Commercial Register (Handelsregister) Bonn Local Court, HRB 15768 (as of 27 September 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Bonn Local Court, HRB 15768 (as of 27 September 2026)
Apogenix GmbH
Heidelberg · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sano Arzneimittelfabrik Gesellschaft mit beschränkter Haftung
Renningen · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
SW Pharma GmbH
Schiffweiler · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sign in to view detailed salary and cost trends.
